Tim Gleeson

CEO BRIJ Medical - President YPO San Diego

📍 United States🔄 Updated September 2026💼 1 investments📅 3 years investing🗓 Last invested Dec 2023
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
3y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
CEO & Board Member (Investor)
Dec 2023
Relieve The Tension around surgical incisions with Brijjit. BRIJ Medical introduces a groundbreaking category in medical technology: the Surgical Incision Tension Management System for closure, support, and scar therapy. Our proven technologies reduce wound complications and scarring, offering enhanced control and confidence at every stage of the healing journey. Our flagship product, the Brijjit, is a force-modulating tissue bridge designed to relieve tension and promote beautiful healing for your patients. - Only Product That Works Across all 3: Closure, Support and Scar Therapy - 90% Reduction in Wound Breakdown - 38% Reduction in Mean Scar Area - 25%+ Tissue Tension Reduction At and Below the Skin Surface - Non-Invasive / No Anesthesia Required - Works on Curves / Non-Linear Incisions - Improves Blood Supply / Perfusion - Fast + Easy Application and Removal - Hypoallergenic / No Skin Irritation
Experience · 3 entries
All (3)
Investments (1)
Founder (2)
Board (1)
2023
CEO & Board Member (Investor)
Dec 2023
Relieve The Tension around surgical incisions with Brijjit. BRIJ Medical introduces a groundbreaking category in medical technology: the Surgical Incision Tension Management System for closure, support, and scar therapy. Our proven technologies reduce wound complications and scarring, offering enhanced control and confidence at every stage of the healing journey. Our flagship product, the Brijjit, is a force-modulating tissue bridge designed to relieve tension and promote beautiful healing for your patients. - Only Product That Works Across all 3: Closure, Support and Scar Therapy - 90% Reduction in Wound Breakdown - 38% Reduction in Mean Scar Area - 25%+ Tissue Tension Reduction At and Below the Skin Surface - Non-Invasive / No Anesthesia Required - Works on Curves / Non-Linear Incisions - Improves Blood Supply / Perfusion - Fast + Easy Application and Removal - Hypoallergenic / No Skin Irritation
2022
Founder
Jan 2022
In todays hyper competitive startup world, founders need more than capital to build great companies. It takes a partner who has lived the entrepreneurial process and who knows what it takes to win at each stage. At VIDANT Capital we focus on investing in earlier-stage healthcare, healthcare technology, healthcare services and consumer facing companies with dynamic management teams, focused on large “white-space” and markets that are ripe for disruption.
2008
Founder (Chairman, CEO)
Feb 2008
Novasyte Health is now part of IQVIA MedTech. This page is no longer active. Follow us on the IQVIA MedTech page. IQVIA MedTech partners with medical device and diagnostic manufacturers, offering tech-enabled, outsourced commercial service teams and technologies. This includes contract clinical, field technical, inside sales and recall support. Our flexible model enables us to deploy and manage teams that expand and contract to meet our clients​ customer-facing needs. Technology is wrapped around all of the offerings and program success is tracked and measured with our real-time business intelligence analytics. This provides our clients with critical insights into their most important resources - their people, patients and customers.